Media Center
Press Releases

Press Releases

30 Jun 15
Global Biosimilars Market Value Could Hit $55 Billion by 2020, says GBI Research

The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active development and government efforts to reduce healthcare spending, according to business intelligence provider GBI Research.

Read post
17 Jun 15
Pancreatic Cancer Treatment Pipeline Dominated by Early-Stage Development, says GBI Research

While the treatment pipeline for pancreatic cancer shows a high level of innovation, with 52% of products categorized as first-in-class, most development is in the early stages, meaning a significant proportion of therapies are unlikely to reach the market in the near future.

Read post
04 Jun 15
Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says GBI Research

The active and diverse treatment pipeline for asthma boasts a striking level of innovation, with many first-in-class products representing significant investment opportunities.

Read post
02 Jun 15
Asia-Pacific Rheumatoid Arthritis Treatment Market Value Will Reach $7 Billion by 2021

The Rheumatoid Arthritis (RA) therapeutics market in the Asia-Pacific (APAC) region will expand in value from $5.6 billion in 2014 to an estimated $7 billion by 2021, at a moderate Compound Annual Growth Rate (CAGR) of 3.3%.

Read post
12 May 15
Muscular Dystrophy Treatment Pipeline Offers Hope for Improved Life Expectancy, says GBI Research

The highly diverse and innovative pipeline for Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) treatment has the potential to produce therapies that will help repair the mutated gene, halt muscle degeneration, and improve patients’ life expectancy.

Read post